Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Use this ZTS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ZTS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ZTS SEC filings page. Lician reads the product cache first so this HTML stays unique to Zoetis Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ZTS income, balance, and cash tables.